Another allogenic vaccine is SV-BR-1-GM (BriaVax), consisting of irradiated HER-2/neu positive breast cancer cells transduced with granulocyte/macrophage-colony stimulating factor (GM-CSF), which was introduced to treat advanced breast cancer cases. The gene discussed is ERBB2; the disease is breast carcinoma.